In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...
AstraZeneca PLC (LON:AZN – Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of £114.82 ($144.52) and traded as high as ...
This move aims to cut air freight emissions significantly, with SAF use reducing emissions by over 80% compared to ...
Hosted on MSN23h
Talazoparib-Enzalutamide Improves Survival in Metastatic CRPCAdding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback